MedTrace Logo

Carotid Body Function in Type 2 Diabetes Mellitus

NCT05237076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-05-31

No results posted yet for this study

Summary

This trial will assess chemosensitivity differences of the carotid bodies in individuals with T2DM, compared to healthy controls. During baseline and hyperinsulinemia.

Conditions

  • Diabetes Mellitus, Type 2
  • Hypoxia

Interventions

DIAGNOSTIC_TEST

Hyperinsulemic-Euglycemic Clamp & Hypoxic Ventilatory Response (HVR)

Hyperinsulemic-Euglycemic Clamp as described by deFronzo et al.

Sponsors & Collaborators

  • Demcon

    collaborator INDUSTRY

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Albert Dahan, MD, PhD · LUMC

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-08-05
Completion
2023-02-15

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05237076 on ClinicalTrials.gov